The Veteran's hidradenitis suppurativa and associated scars have been granted initial evaluations, with the most recent evaluation being a 60 percent rating since July 5, 2018. The TDIU claim is also remanded.
The deciding factor: The Veteran’s hidradenitis suppurativa has manifested as more than 40% of his entire body affected and required constant systemic therapy (corticosteroids) over the past 12-month period, warranting a 60 percent evaluation under the General Rating Formula for the Skin.
- Claimed conditions
- hidradenitis suppurativa
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating
- Not verified here — check the original decision
- Decision date
- September 23, 2020
- Citation
- 20062447
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Read the original VA decision (opens in a new tab) using citation 20062447.
What this means for you
A grant means the Board allowed the benefit or issue identified in this decision. Review the original order: other issues in the same appeal may have a different outcome, and this decision does not predict another claim.
What you can do next
Use your own notice and decision stage. A remanded issue is not a final court-appealable denial. VA review guidance and CAVC filing instructions (U.S. federal; reviewed October 7, 2026).
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Whole decision: Denied
The Veteran's hidradenitis suppurativa is rated at 10 percent, which does not meet the criteria for a higher rating under VA regulations.,The Veteran's tension headaches do not meet the criteria for a compensable disability rating as there are no characteristic prostrating attacks averaging one in two months over the last several months.
- Whole decision: Granted
The Board has granted service connection for hidradenitis suppurativa, a cyst condition that the Veteran first experienced during active duty in 2008. The decision is based on the Veteran's competent lay testimony and medical evidence showing current disability and continuity of symptoms since service.
- Whole decision: Dismissed
The appeal regarding the denial of service connection for hidradenitis suppurativa, a bilateral armpit disability, in a June 2016 rating decision is dismissed due to procedural defects.
- Whole decision: Granted
The Veteran's hidradenitis suppurativa is granted a 60 percent disability rating, effective from the date of the decision. The claim for TDIU has been remanded.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.